Larson Financial Group LLC - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 86 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Larson Financial Group LLC ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$41,200
-37.5%
4,0000.0%0.00%
-42.9%
Q2 2023$65,920
+79.9%
4,0000.0%0.01%
+75.0%
Q1 2023$36,640
+27.9%
4,0000.0%0.00%
+33.3%
Q4 2022$28,640
+43.2%
4,0000.0%0.00%0.0%
Q3 2022$20,000
+100.0%
4,0000.0%0.00%
+50.0%
Q2 2022$10,000
-63.0%
4,0000.0%0.00%
-50.0%
Q1 2022$27,000
-15.6%
4,0000.0%0.00%
-20.0%
Q4 2021$32,000
-17.9%
4,0000.0%0.01%
-37.5%
Q3 2021$39,000
+44.4%
4,0000.0%0.01%
+33.3%
Q2 2021$27,000
-25.0%
4,0000.0%0.01%
-45.5%
Q1 2021$36,000
+33.3%
4,0000.0%0.01%
+22.2%
Q4 2020$27,000
+35.0%
4,0000.0%0.01%
+12.5%
Q3 2020$20,000
-37.5%
4,0000.0%0.01%
-46.7%
Q2 2020$32,0000.0%4,0000.0%0.02%
-25.0%
Q1 2020$32,000
+6.7%
4,0000.0%0.02%
+17.6%
Q4 2019$30,000
+76.5%
4,0000.0%0.02%
+54.5%
Q3 2019$17,0004,0000.01%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q1 2022
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 2,305,017$18,625,0007.73%
COWEN AND COMPANY, LLC 3,732,778$30,161,0002.74%
GENDELL JEFFREY L 2,446,299$19,766,0001.60%
Asymmetry Capital Management, L.P. 369,134$2,983,0001.58%
Vivo Capital, LLC 2,937,093$23,732,0001.43%
Samsara BioCapital, LLC 659,409$5,328,0001.03%
Altium Capital Management LP 440,589$3,560,0000.98%
Knott David M Jr 258,198$2,086,0000.71%
RTW INVESTMENTS, LP 5,741,939$46,395,0000.68%
FRAZIER MANAGEMENT LLC 951,814$7,691,0000.59%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders